Meeting report: the 2021 FSHD International Research Congress
Abstract Facioscapulohumeral muscular dystrophy (FSHD) is the second most common genetic myopathy, characterized by slowly progressing and highly heterogeneous muscle wasting with a typical onset in the late teens/early adulthood [1]. Although the etiology of the disease for both FSHD type 1 and typ...
Main Authors: | Sujatha Jagannathan, Jessica C. de Greef, Lawrence J. Hayward, Kyoko Yokomori, Davide Gabellini, Karlien Mul, Sabrina Sacconi, Jamshid Arjomand, June Kinoshita, Scott Q. Harper |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2022-01-01
|
Series: | Skeletal Muscle |
Online Access: | https://doi.org/10.1186/s13395-022-00287-8 |
Similar Items
-
Meeting report: the 2020 FSHD International Research Congress
by: Michael Kyba, et al.
Published: (2020-12-01) -
DUX4 Role in Normal Physiology and in FSHD Muscular Dystrophy
by: Emanuele Mocciaro, et al.
Published: (2021-11-01) -
MATR3 is an endogenous inhibitor of DUX4 in FSHD muscular dystrophy
by: Valeria Runfola, et al.
Published: (2023-09-01) -
DNA methylation analysis of the macrosatellite repeat associated with FSHD muscular dystrophy at single nucleotide level.
by: Claudia Huichalaf, et al.
Published: (2014-01-01) -
Single-nucleus RNA-seq identifies divergent populations of FSHD2 myotube nuclei.
by: Shan Jiang, et al.
Published: (2020-05-01)